IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 192 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,757,197 | +15.3% | 1,324,735 | +26.0% | 0.07% | +15.9% |
| Q2 2023 | $11,064,703 | +0.3% | 1,051,046 | +0.2% | 0.06% | 0.0% |
| Q1 2023 | $11,035,616 | -14.2% | 1,049,013 | +1.1% | 0.06% | -16.0% |
| Q4 2022 | $12,856,681 | +6.5% | 1,037,666 | -10.9% | 0.08% | -1.3% |
| Q3 2022 | $12,071,000 | -19.8% | 1,165,208 | -10.7% | 0.08% | -13.6% |
| Q2 2022 | $15,045,000 | -17.3% | 1,304,913 | -9.8% | 0.09% | -1.1% |
| Q1 2022 | $18,201,000 | +44.6% | 1,446,899 | +34.0% | 0.09% | +48.3% |
| Q4 2021 | $12,589,000 | -11.8% | 1,079,826 | -1.2% | 0.06% | -18.9% |
| Q3 2021 | $14,269,000 | +1.0% | 1,092,610 | -0.5% | 0.07% | +1.4% |
| Q2 2021 | $14,127,000 | +14.9% | 1,097,813 | -0.2% | 0.07% | +10.6% |
| Q1 2021 | $12,300,000 | +33.1% | 1,100,301 | +35.6% | 0.07% | +29.4% |
| Q4 2020 | $9,241,000 | +14.2% | 811,463 | -9.8% | 0.05% | +6.2% |
| Q3 2020 | $8,094,000 | +40370.0% | 899,965 | +44277.0% | 0.05% | – |
| Q2 2020 | $20,000 | -23.1% | 2,028 | 0.0% | 0.00% | – |
| Q1 2020 | $26,000 | 0.0% | 2,028 | 0.0% | 0.00% | – |
| Q4 2019 | $26,000 | +52.9% | 2,028 | 0.0% | 0.00% | – |
| Q3 2019 | $17,000 | -22.7% | 2,028 | 0.0% | 0.00% | – |
| Q2 2019 | $22,000 | -18.5% | 2,028 | 0.0% | 0.00% | – |
| Q1 2019 | $27,000 | +28.6% | 2,028 | -1.4% | 0.00% | – |
| Q4 2018 | $21,000 | -43.2% | 2,057 | +1.4% | 0.00% | – |
| Q3 2018 | $37,000 | -5.1% | 2,029 | 0.0% | 0.00% | – |
| Q2 2018 | $39,000 | +25.8% | 2,029 | -3.8% | 0.00% | – |
| Q1 2018 | $31,000 | 0.0% | 2,110 | 0.0% | 0.00% | – |
| Q4 2017 | $31,000 | -6.1% | 2,110 | 0.0% | 0.00% | – |
| Q3 2017 | $33,000 | -5.7% | 2,110 | 0.0% | 0.00% | – |
| Q2 2017 | $35,000 | 0.0% | 2,110 | 0.0% | 0.00% | – |
| Q1 2017 | $35,000 | +9.4% | 2,110 | 0.0% | 0.00% | – |
| Q4 2016 | $32,000 | -5.9% | 2,110 | -4.1% | 0.00% | – |
| Q3 2016 | $34,000 | +25.9% | 2,200 | +4.3% | 0.00% | – |
| Q2 2016 | $27,000 | +17.4% | 2,110 | 0.0% | 0.00% | – |
| Q1 2016 | $23,000 | 0.0% | 2,110 | +5.5% | 0.00% | – |
| Q4 2015 | $23,000 | +15.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2015 | $20,000 | -16.7% | 2,000 | 0.0% | 0.00% | – |
| Q2 2015 | $24,000 | -25.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2015 | $32,000 | +6.7% | 2,000 | 0.0% | 0.00% | – |
| Q4 2014 | $30,000 | +20.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2014 | $25,000 | -16.7% | 2,000 | 0.0% | 0.00% | – |
| Q2 2014 | $30,000 | +25.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2014 | $24,000 | +4.3% | 2,000 | 0.0% | 0.00% | – |
| Q4 2013 | $23,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2013 | $23,000 | +21.1% | 2,000 | 0.0% | 0.00% | – |
| Q2 2013 | $19,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |